The epidemiology of primary degenerative dementia and related neurological disorders

  • Brian Cooper
The Epidemiology of Dementia

Summary

Observation of cytopathological similarities between the changes of Alzheimer-type dementia, Parkinson's disease and motor neuron disease, as well as of some degree of clinical association between these conditions, has led to the suggestion that all three belong to a common class of degenerative neurological disorders, each of which as a rule first becomes manifest when agerelated neuronal attrition is superimposed on subclinical damage caused by environmental noxae earlier in life. The importance of this model lies in its potential relevance to prevention. The epidemiological data reviewed here suggest that, while the three disease groups are all strongly linked with ageing, there may be major differences between their patterns of occurrence in populations, which make it doubtful if the same environmental pathogens are responsible in each instance. The most plausible unifying hypothesis at present is that the predisposing neuronal damage can be caused by a number of widely distributed metallic neurotoxins, each of which has a tendency to pick out specific areas or cell groups within the CNS and thus to give rise to distinct though overlapping clinical syndromes. The evidence bearing on this and other causal hypotheses is, however, still tenuous because of the scarcity of empirical data. Population-based case-control and cohort studies are called for, as part of a co-ordinated research endeavour.

Key words

Epidemiology Dementia Parkinsonism Motor neuron disease 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Abd el Naby S, Hassanein M (1965) Neuropsychiatric manifestations of chronic manganese poisoning. J Neurol Neurosurg Psychiatry 28:282–288Google Scholar
  2. 2.
    Amaducci LA, Fratiglioni L, Rocca WA, Fieschi C, Livrea P, Pedone D, Bracco L, Lippi A, Gandolfo C, Bino G, Prencipe M, Bonatti ML, Girotti F, Carella F, Tavolato B, Ferla S, Lenzi GL, Carolei A, Gambi A, Grigoletto F, Schoenberg BS (1986) Risk factors for clinically diagnosed Alzheimer's disease. Neurology 36:922–931Google Scholar
  3. 3.
    Appel SH (1981) A unifying hypothesis for the cause of amyotrophic lateral sclerosis, Parkinsonism and Alzheimer disease. Ann Neurol 10:499–505Google Scholar
  4. 4.
    Ball MJ, Hachinski V, Fox A, Kirshen AJ, Fisman M, Blume W, Kral VA, Fox H (1985) A new definition of Alzheimer's disease: a hippocampal dementia. Lancet I:14–16Google Scholar
  5. 5.
    Barbeau A, Pourcher E (1982) New data on the genetics of Parkinson's disease, Can J Neurol Sci 9:53–60Google Scholar
  6. 6.
    Baruah JK, Ho KC, Glatt SL, Sulaiman AR (1985) Dementia and amyotrophic lateral sclerosis (ALS). Neurology 35 [Suppl]:181Google Scholar
  7. 7.
    Bergmann K, Kay DWK, Foster EM, McKechnie AA, Roth M (1971) A follow-up study of randomly selected community residents to assess the effects of chronic brain syndrome. Psychiatry, part II. Excerpta Med Ser 274:856–865.Google Scholar
  8. 8.
    Bharucha NE, Schoenberg BS, Raven RH, Pickle LW, Byar DP, Mason TJ (1983) Geographic distribution of motor neuron disease and correlation with possible aetiologic factors. Neurology 33:911–915Google Scholar
  9. 9.
    Bobowick AR, Brody KA (1973) Epidemiology of motor neuron diseases. N Engl J Med 288:1047–1055Google Scholar
  10. 10.
    Brewis M, Poskanzer DC, Rolland C, Miller M (1966) Neurological disease in an English city. Acta Neurol Scand 24 [Suppl]:8–89Google Scholar
  11. 11.
    Brown RG, Marsden CD (1984) How common is dementia in Parkinson's disease? Lancet II:1262–1265Google Scholar
  12. 12.
    Buckley J, Warlow C, Smith P, Hilton-Jones D, Irvine S, Tew JR (1983) Motor neuron disease in England & Wales, 1959–79. J Neurol Neurosurg Psychiatry 46:197–205Google Scholar
  13. 13.
    Calne DB, Eisen A (1989) The relationship between Alzheimer's disease, Parkinson's disease and motor neurone disease. Can J Neurol Sci 16 [Suppl]:547–550Google Scholar
  14. 14.
    Calne DB, Langston JW (1983) Aetiology of Parkinson's disease. Lancet II:1457–1459Google Scholar
  15. 15.
    Calne DB, Eisen A, McGeer F, Spencer P (1986) Alzheimer's disease, Parkinson's disease and motor neurone disease: abiotrophic interaction between aging and environment? Lancet II:1067–1070Google Scholar
  16. 16.
    Campbell AJ, McCosh LM, Reinkew J, Allan BC (1983) Dementia in old age and the need for services. Age Aging 12:11–16Google Scholar
  17. 17.
    Campbell AMG, Williams DR, Barltrop D (1970) Motor neurone disease and exposure to lead. J Neurol Neurosurg Psychiatry 33:877–885Google Scholar
  18. 18.
    Cawte J, Hams G, Kilburn C (1987) Manganese in a neurological ethnic complex in Northern Australia. Lancet I:1257Google Scholar
  19. 19.
    Cendrowski W, Wender M, Owsianowski M (1970) Epidemiological analysis of amyotrophic lateral sclerosis in the territory of Wielkopolska, based on medical records. Neurol Neurochir Pol 4:425–431 (cited in [9] Bobowick AR, Brody KA (1973) Epidemiology of motor neuron diseases. N Engl J Med 288:1047–1055)Google Scholar
  20. 20.
    Chandra V, Kokmen E, Schoenberg BS, Beard CM (1989) Head trauma with loss of consciousness as risk factor for Alzheimer's disease. Neurology 39:1576–1578Google Scholar
  21. 21.
    Cook RH, Ward BE, Austin JH (1979) Studies in aging of the brain. IV. Familial Alzheimer's disease: relation to transmissible dementia, aneuploidy and microtubular defects. Neurology 29:1402–1412Google Scholar
  22. 22.
    Cooper B, Bickel H (1989) Prävalenz und Inzidenz von Demenzerkrankungen in der Altenbevölkerung. Nervenarzt 60:472–482Google Scholar
  23. 23.
    Cooper B, Sosna U (1983) Psychische Erkrankung in der Altenbevölkerung. Eine epidemiologische Feldstudie in Mannheim. Nervenarzt 54:239–249Google Scholar
  24. 24.
    Dalakas MC, Elder G, Hallett M, Ravits J, Baker M, Papadopoulos N, Albrecht P, Sever J (1986) A long-term follow-up study of patients with post-poliomyelitis neuromuscular symptoms. N Engl J Med 314:959–963Google Scholar
  25. 25.
    De Pedro Cuesta J (1986) Studies on the prevalence of paralysis agitans by tracer methodology. Karolinska Institute, Huddinge, Sweden (cited in [82] Schoenberg BS (1987) Environmental risk factors for Parkinson's disease: the environmental evidence. Can J Neurol Sci 14:407–413)Google Scholar
  26. 26.
    Dunea G, Mahurka SD, Mamdani B, Smith EC (1978) Role of aluminium in dialysis dementia. Ann Intern Med 88:502–504Google Scholar
  27. 27.
    Duvoisin RC, Schweitzer MD (1966) Paralysis agitans mortality in England and Wales, 1855–1962. Br J Prev Med 20:27–33Google Scholar
  28. 28.
    Eldridge R, Rocca WA (1990) Parkinson's disease: etiologic considerations. In: King RA, Rotter JI, Motulsky AG (eds) The genetic basis of common diseases. University Press, New York (in press)Google Scholar
  29. 29.
    Essen-Möller E (1956) Individual traits and morbidity in a Swedish rural population. Acta Psychiatr Scand 100 [Suppl]:1–160Google Scholar
  30. 30.
    Evans JG, Caird FI (1982) Epidemiology of neurological disorders in old age. In: Caird FI (ed) Neurological disorders in the elderly. Wright, Bristol, pp 1–16Google Scholar
  31. 31.
    Flaten TP (1989) Geographical associations between aluminium in drinking water and death rates from dementia (including Alzheimer's disease), Parkinsons disease and amyotrophic lateral sclerosis in Norway. Environ Geogr Health 11 [Suppl]:7–20Google Scholar
  32. 32.
    Folstein MF, Powell D (1984) Is Alzheimer's disease inherited?: a methodological review. Integrated Psychiatry (Sept.–Oct.). Elsevier, Amsterdam, pp 163–170Google Scholar
  33. 33.
    Gardner MJ, Winter PD, Barker DJP (1984) Atlas of mortality from selected diseases in England and Wales. Wiley, New YorkGoogle Scholar
  34. 34.
    Garruto RM, Gajdusek DC, Chen KW (1980) Amyotrophic lateral sclerosis among Chamorro migrants from Guam. Ann Neurol 8:612–619Google Scholar
  35. 35.
    Garruto RM, Yanagihara R, Gajdusek DC (1985) Disappearance of high-incidence amyotrophic lateral sclerosis and parkinsonism-dementia on Guam. Neurology 35:193–198Google Scholar
  36. 36.
    Gibbs CJ, Gajdusek DC (1982) An update on long-term in vivo and in vitro studies designed to identify a virus as the cause of amyotrophic lateral sclerosis, Parkinsonism dementia and Parkinson's disease. In: Rowland LP (ed) Human motor neuron disease. Raven Press, New York, pp 343–353Google Scholar
  37. 37.
    Gowers WR (1902) A lecture on abiotrophy. Lancet I:1003–1007Google Scholar
  38. 38.
    Granieri E, Carreras M, Tola R, Paolino E, Tralli G, Eleopra R, Serra G (1988) Motor neuron disease in the province of Ferrara, Italy, in 1964–1982, Neurology 38:1604–1608Google Scholar
  39. 39.
    Gudmundsson KR (1968) The prevalence of some neurological diseases in Iceland. Acta Neurol Scand 44:57–69Google Scholar
  40. 40.
    Haberlandt WF (1959) Zur Genetik und Demographie der Charcotschen Krankheit im Raum von Westfalen. Dtsch Z Nervenheilkd 180:55–83Google Scholar
  41. 41.
    Hagnell O, Lanke J, Rorsman B, Öjesjö L (1981) Does the incidence of age psychosis decrease? A prospective longitudinal study of a complete population, 1947–74. Neuropsychobiology 7:201–211Google Scholar
  42. 42.
    Hanisch R, Dworsky RL, Henderson BE (1976) A search for clues to the cause of amyotrophic lateral sclerosis. Arch. Neurol 33:456Google Scholar
  43. 43.
    Henderson AS (1988) The risk factors for Alzheimer's disease: a review and hypothesis. Acta Psychiatr Scand 78:257–275Google Scholar
  44. 44.
    Heston LL, Mastri AR, Anderson E, White J (1981) Dementia of the Alzheimer type: clinical genetics, natural history and associated conditions. Arch Gen Psychiatry 38:1085–1090Google Scholar
  45. 45.
    Hoffman PM, Brody JA (1971) The reliability of death certificate reporting for amyotrophic lateral sclerosis. J Chronic Dis 24:5–8Google Scholar
  46. 46.
    Hofman A, Rocca WA, Brayne C, Breteler MMB, Clarke M, Cooper B, Copeland JRM, Dartigues JF, da Silva Droux A, Hagnell O, Heeren TJ, Engedal K, Jonker C, Lindesay J, Lobo A, Mann AH, Mölsa PK, Morgan K, O'Connor DW, Sulkava R, Kay DWK, Amaducci L (1990) The prevalence of dementia in Europe: a collaborative study of 1980–1990 findings. Am J Epidemiol (in press)Google Scholar
  47. 47.
    Holloway SM, Mitchell JD (1986) Motor neurone disease in the Lothian Region of Scotland 1961–81. J Epidemiol Community Health 40:344–350Google Scholar
  48. 48.
    Hudson AJ (1981) Amyotrophic lateral sclerosis and its association with dementia, parkinsonism and other neurological disorders: a review. Brain 104:217–247Google Scholar
  49. 49.
    Jankins AC (1966) Epidemiology of parkinsonism in Victoria. Med J Aust 2:496–502Google Scholar
  50. 50.
    Jokelainen M (1976) The epidemiology of amyotrophic lateral sclerosis in Finland. A study based on the death certificates of 421 patients. Can J Neurol Sci 29:55–63Google Scholar
  51. 51.
    Jorm A, Korten AE, Henderson AS (1987) The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand 76:465–479Google Scholar
  52. 52.
    Kahana E, Alter M, Feldman S (1976) Amyotrophic lateral sclerosis: a population study. J Neurol 212:205–213Google Scholar
  53. 53.
    Kaneko Z (1975) Care in Japan In: Howells JG (ed) Modern perspectives in the psychiatry of old age. Brunner-Mazel, New York, pp 519–539Google Scholar
  54. 54.
    Kantarjian AD (1960) A syndrome clinically resembling amyotrophic lateral sclerosis following chronic mercurialism. Neurology 11:639–644Google Scholar
  55. 55.
    Kay DWK, Bergmann K, Foster EM, McKechnie AH, Roth M (1970) Mental illness and hospital usage in the elderly: a random sample followed up. Comp Psychiatry 11:26–35Google Scholar
  56. 56.
    Kessler II (1972) Epidemiological studies of Parkinson's disease. III. A community-based survey. Am J Epidemiol 96:242–254Google Scholar
  57. 57.
    Kessler II (1978) Parkinson's disease in epidemiologic perspective. Adv Neurol 19:355–384Google Scholar
  58. 58.
    Khondkarian OQ, Maksudow GA (1970) Epidemiology of amyotrophic lateral sclerosis. Vestn Akad Med Nauk SSR 25:83–86 (cited in [9] Bobowick AR, Brody KA (1973) Epidemiology of motor neuron diseases. N Engl J Med 288:1047–1055)Google Scholar
  59. 59.
    Kimura K, Yase Y, Higashi S, Uno S, Yamamoto K, Iwasaki M, Tsumoto I, Sugiura M, Yoshimura S, Namikawa K, Kumura J, Iwamoto S, Yamamoto I, Handa Y, Yata M, Yata Y (1963) Epidemiological and geomedical studies on amyotrophic lateral sclerosis. Dis Nerv Syst 24:155–159Google Scholar
  60. 60.
    Kokmen E, Chandra V, Schoenberg BS (1988) Trends in incidence of dementing illness in Rochester, Minnesota, in three quinquennial periods, 1960–1974. Neurology 38:975–980Google Scholar
  61. 61.
    Kondo K (1978) Motor neuron disease: changing population patterns and clues for aetiology. Adv Neurol 19:509–543Google Scholar
  62. 62.
    Kreindler A, Ionescu V, Drinca-Ionescu M (1964) Distribution of hereditary neurological diseases in Rumania. Stud Cercet Neurol 9:401–410 (cited in [9] Bobowick AR, Brody KA (1973) Epidemiology of motor neuron diseases. N Engl J Med 288:1047–1055)Google Scholar
  63. 63.
    Kurland LT (1958) Descriptive epidemiology of selected neurologic and myopathic disorders, with particular reference to a survey in Rochester, Minnesota. J Chronic Dis 8:378–418Google Scholar
  64. 64.
    Kurland LT, Mulder DW (1954) Epidemiologic investigations of amyotrophic lateral sclerosis. Neurology 4:355–378, 438–448Google Scholar
  65. 65.
    Kurland LT, Kurtzke JF, Goldberg ID (eds) Epidemiology of neurologic and sense organ disorders. Harvard University Press, Cambridge, Mass.Google Scholar
  66. 66.
    Kurtzke JF (1984) Neuroepidemiology. Ann Neurol 16:265–277Google Scholar
  67. 67.
    Lewin R (1985) Parkinson's disease: an environmental cause? Science 229:257–258Google Scholar
  68. 68.
    Lilienfeld DE, Ehland J, Landrigan PJ, Chan E, Godbold J, Marsh G, Perl DP (1989) Rising mortality from motor neuron disease in the U.S.A., 1962–84. Lancet I:710–712Google Scholar
  69. 69.
    Lorez A (1969) Ein Beitrag zu Klinik und Vorkommen der amyotrophischen Lateralsklerose (isolierte und familiäre Fälle). Schweiz Med Wochenschr 99:51–57Google Scholar
  70. 70.
    Martyn CN, Pippard EC (1988) Usefulness of mortality data in determining the geography and time trends of dementia. J Epidemiol community Health 42:134–137Google Scholar
  71. 71.
    Martyn CN, Barker DJP, Osmond C (1988) Motoneuron disease and past poliomyelitis in England and Wales. Lancet I: 1319–1321Google Scholar
  72. 72.
    Martyn CN, Osmond C, Edwardson JA, Barker DJP, Harris EC, Lacey RF (1989) Geographical relation between Alzheimer's disease and aluminium in drinking water. Lancet I:59–62Google Scholar
  73. 73.
    Mikkelsen S (1980) A cohort study of disability pension and death among painters, with special regard to disabling presenile dementia as an occupational disease. Scand J Soc Med 16:34–43Google Scholar
  74. 74.
    Mortimer J (1988) Do psychosocial factors contribute to Alzheimer's disease? In: Henderson AS, Henderson JH (eds) Etiology of dementia of Alzheimer's type. Wiley, Chichester, pp 39–52Google Scholar
  75. 75.
    Mutch WJ, Dingwall-Fordyce I, Downie AW, Paterson JG, Roy SK (1986) Parkinson's disease in a Scottish city. Br Med J 292:534–536Google Scholar
  76. 76.
    New York State Department of Mental Hygiene (1961) A Mental Health Survey of Older People. State Hospitals Press, Utica, N. Y.Google Scholar
  77. 77.
    Nielsen J (1962) Geronto-psychiatric period-prevalence investigation in a geographically delimited population. Acta Psychiatr Scand 38:307–330Google Scholar
  78. 78.
    Nielsen JA, Biörn-Henriksen T, Bork BR (1982) Incidence and disease expectance for senile and arteriosclerotic dementia in a geographically delimited Danish population. In: Magnussen J, Nielsen J, Buch J (eds) Epidemiology and prevention of mental illness in old age. EGV, Hellerup, Denmark, pp 52–53Google Scholar
  79. 79.
    Nilsson LV (1984) Incidence of severe dementia in an urban sample followed up from 70 to 79 years of age. Acta Psychiatr Scand 70:478–486Google Scholar
  80. 80.
    Olsen MI, Shaw CM (1969) Presenile dementia and Alzheimer's disease in mongolism. Brain 92:147–156Google Scholar
  81. 81.
    Poskanzer DC, Schwab RS (1963) Cohort analysis of Parkinson's syndrome. Evidence for a single aetiology related to subclinical infection about 1920. J Chronic Dis 16:961–973Google Scholar
  82. 82.
    Schoenberg BS (1987) Environmental risk factors for Parkinson's disease: the environmental evidence. Can J Neurol Sci 14:407–413Google Scholar
  83. 83.
    Schoenberg BS, Anderson DW, Haerer AF (1985) Prevalence of Parkinson's disease in the biracial population of Copiah County, Mississippi. Neurology 35:841–845Google Scholar
  84. 84.
    Schoenberg BS, Kokmen E, Okazaki H (1987) Alzheimer's disease and other dementing illnesses in a defined U.S. population: incidence rates and clinical features. Ann Neurol 22:724–729Google Scholar
  85. 85.
    Spencer PS, Nunn PB, Hugon J, Ludolph A, Roy DN (1986) Motor neurone disease on Guam: possible role of food neurotoxin. Lancet I:965Google Scholar
  86. 86.
    Ward CD, Duvoisin RC, Ince SE, Nutt JD, Eldridge R, Calne DB (1983) Parkinson's disease in 65 pairs of twins and in a set of quadruplets. Neurology 33:815–824Google Scholar
  87. 87.
    World Health Organization (1987) ICD-10: 1968 Draft of Chapter V. Mental, behavioural and developmental disorders. WHO, GenevaGoogle Scholar
  88. 88.
    Yase Y (1972) The pathogenesis of amyotrophic lateral sclerosis. Lancet II:292–296Google Scholar

Copyright information

© Springer-Verlag 1991

Authors and Affiliations

  • Brian Cooper
    • 1
  1. 1.Department of Epidemiological PsychiatryCentral Institute of Mental HealthMannheim 1Federal Republic of Germany

Personalised recommendations